Corticosteroids for Patients With Coronavirus Disease 2019 (COVID-19) With Different Disease Severity: A Meta-Analysis of Randomized Clinical Trials

Wong, 2019, Insights into the immuno-pathogenesis of acute respiratory distress syndrome, Ann Transl Med, 7, 504, 10.21037/atm.2019.09.28

Hamming, 2004, Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis, J Pathol, 203, 631, 10.1002/path.1570

Ciceri, 2020, Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): An atypical acute respiratory distress syndrome working hypothesis, Crit Care Resusc

Tan, 2020, Critically ill COVID-19 infected patients exhibit increased clot waveform analysis parameters consistent with hypercoagulability, Am J Hematol, 95, E156, 10.1002/ajh.25822

Nardelli, 2020, COVID-19-related thromboinflammatory status: Microclots and beyond (editorial), Obshchaya Reanimatologiya, 16, 14, 10.15360/1813-9779-2020-3-0-2

Lewis, 2019, Pharmacological agents for adults with acute respiratory distress syndrome, Cochrane Database Syst Rev, 7

Villar, 2020, Rationale for prolonged corticosteroid treatment in the acute respiratory distress syndrome caused by coronavirus disease 2019, Crit Care Explor, 2, e0111, 10.1097/CCE.0000000000000111

Lim, 2020, Dexamethasone in Hospitalized patients with covid-19 – Preliminary report [E-pub ahead of print], N Engl J Med

Lamontagne, 2020, A living WHO guideline on drugs for covid-19, BMJ, 370, m3379, 10.1136/bmj.m3379

Jeronimo, 2020, Methylprednisolone as adjunctive therapy for patients hospitalized with COVID-19 (metcovid): A randomised, double-blind, phase IIb, placebo-controlled trial, Clin Infect Dis

Dequin, 2020, Effect of hydrocortisone on 21-day mortality or respiratory support among critically ill patients with COVID-19: A randomized clinical trial, JAMA, 324, 1298, 10.1001/jama.2020.16761

Angus, 2020, Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: The REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial, JAMA, 324, 1317, 10.1001/jama.2020.17022

Tomazini, 2020, Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial, JAMA, 324, 1307, 10.1001/jama.2020.17021

Sterne, 2020, Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: A meta-analysis, JAMA, 324, 1330, 10.1001/jama.2020.17023

Sterne, 2019, RoB 2: A revised tool for assessing risk of bias in randomised trials, BMJ, 366, l4898, 10.1136/bmj.l4898

Higgins, 2019

Liberati, 2009, The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: Explanation and elaboration, BMJ, 339, b2700, 10.1136/bmj.b2700

Fernández Cruz, 2020, Impact of glucocorticoid treatment in SARS-COV-2 infection mortality: A retrospective controlled cohort study, Antimicrob Agents Chemother, 64, 10.1128/AAC.01168-20

Zha, 2020, Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19), Med J Aust, 212, 416, 10.5694/mja2.50577

Wu, 2020, Systemic corticosteroids and mortality in severe and critical COVID-19 patients in Wuhan, China, J. Clin. Endocrinol. Metab, 10.1210/clinem/dgaa627

Fadel, 2020, Early Short Course Corticosteroids in Hospitalized Patients with COVID-19, Clin Infect Dis, 71, 2114, 10.1093/cid/ciaa601

Rubio-Rivas, 2020, Beneficial Effect of Corticosteroids in Preventing Mortality in Patients Receiving Tocilizumab to Treat Severe COVID-19 Illness AUTHORS, Int J Infect Dis., 101, 290, 10.1016/j.ijid.2020.09.1486

Corral, 2020, GLUCOCOVID: A controlled trial of methylprednisolone in adults hospitalized with COVID-19 pneumonia, medRxiv

Pei, 2020, Antiviral agents, glucocorticoids, antibiotics, and intravenous immunoglobulin usage in 1142 patients with coronavirus disease 2019: A systematic review and meta-analysis, Polish Arch Intern Med, 130, 726

Hasan, 2020, Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: A systematic review and meta-analysis, Expert Rev Respir Med, 14, 1149, 10.1080/17476348.2020.1804365

Martino, 2018, Steroids and Survival in Critically Ill Adult Patients: A Meta-analysis of 135 Randomized Trials, J Cardiothorac Vasc Anesth, 32, 2252, 10.1053/j.jvca.2018.04.017

Ciceri, 2020, Decreased in-hospital mortality in patients with COVID-19 pneumonia, Pathog Glob Health, 114, 281, 10.1080/20477724.2020.1785782

Cavalli, 2020, Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: A retrospective cohort study, Lancet Rheumatol, 2, e325, 10.1016/S2665-9913(20)30127-2